APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cellular Therapy Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cellular Therapy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026198 pages

Choose your research edition.

Industry ResearchCellular Therapy Products Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cellular Therapy Products Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Cellular Therapy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cellular Therapy Products Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cellular Therapy Products Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Cellular Therapy Products market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cellular Therapy Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cellular Therapy Products include Beike Biotechnology, Fujifilm Cellular Dynamics, Gilead Sciences, Golden Meditech, Guanhao Biotech, JCR Pharmaceuticals, Osiris, Vcanbio and Vericel Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cellular Therapy Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cellular Therapy Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cellular Therapy Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cellular Therapy Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Cellular Therapy Products Segment by Company

Beike Biotechnology

Fujifilm Cellular Dynamics

Gilead Sciences

Golden Meditech

Guanhao Biotech

JCR Pharmaceuticals

Osiris

Vcanbio

Vericel Corporation

Novartis

Cellular Therapy Products Segment by Type

Stem Cell Type

Non-Stem Cell Type

Cellular Therapy Products Segment by Application

Hospital

Clinic

Others

Cellular Therapy Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cellular Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cellular Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cellular Therapy Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cellular Therapy Products market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cellular Therapy Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cellular Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cellular Therapy Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cellular Therapy Products Industry Trends Table 2. Cellular Therapy Products Industry Drivers Table 3. Cellular Therapy Products Industry Opportunities and Challenges Table 4. Cellular Therapy Products Industry Restraints Table 5. Global Cellular Therapy Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cellular Therapy Products Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cellular Therapy Products Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cellular Therapy Products Sales Market Share by Manufacturers Table 9. Global Cellular Therapy Products Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cellular Therapy Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cellular Therapy Products Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cellular Therapy Products Manufacturers, Product Type & Application Table 13. Global Cellular Therapy Products Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cellular Therapy Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Stem Cell Type Table 17. Major Manufacturers of Non-Stem Cell Type Table 18. Global Cellular Therapy Products Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cellular Therapy Products Sales by Type (2021-2026) & (K Units) Table 20. Global Cellular Therapy Products Sales by Type (2027-2032) & (K Units) Table 21. Global Cellular Therapy Products Sales Market Share by Type (2021-2026) Table 22. Global Cellular Therapy Products Sales Market Share by Type (2027-2032) Table 23. Global Cellular Therapy Products Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cellular Therapy Products Revenue by Type (2021-2026) & (K Units) Table 25. Global Cellular Therapy Products Revenue by Type (2027-2032) & (K Units) Table 26. Global Cellular Therapy Products Revenue Market Share by Type (2021-2026) Table 27. Global Cellular Therapy Products Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Others Table 31. Global Cellular Therapy Products Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Cellular Therapy Products Sales by Application (2021-2026) & (K Units) Table 33. Global Cellular Therapy Products Sales by Application (2027-2032) & (K Units) Table 34. Global Cellular Therapy Products Sales Market Share by Application (2021-2026) Table 35. Global Cellular Therapy Products Sales Market Share by Application (2027-2032) Table 36. Global Cellular Therapy Products Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cellular Therapy Products Revenue by Application (2021-2026) & (K Units) Table 38. Global Cellular Therapy Products Revenue by Application (2027-2032) & (K Units) Table 39. Global Cellular Therapy Products Revenue Market Share by Application (2021-2026) Table 40. Global Cellular Therapy Products Revenue Market Share by Application (2027-2032) Table 41. Global Cellular Therapy Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cellular Therapy Products Sales by Region (2021-2026) & (K Units) Table 43. Global Cellular Therapy Products Sales Market Share by Region (2021-2026) Table 44. Global Cellular Therapy Products Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Cellular Therapy Products Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Cellular Therapy Products Sales by Country (2021-2026) & (K Units) Table 48. North America Cellular Therapy Products Sales by Country (2027-2032) & (K Units) Table 49. Europe Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Cellular Therapy Products Sales by Country (2021-2026) & (K Units) Table 51. Europe Cellular Therapy Products Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Cellular Therapy Products Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Cellular Therapy Products Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Cellular Therapy Products Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Cellular Therapy Products Sales by Country (2027-2032) & (K Units) Table 58. Global Cellular Therapy Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cellular Therapy Products Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cellular Therapy Products Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cellular Therapy Products Revenue Market Share by Region (2021-2026) Table 62. Global Cellular Therapy Products Revenue Market Share by Region (2027-2032) Table 63. Beike Biotechnology Company Information Table 64. Beike Biotechnology Business Overview Table 65. Beike Biotechnology Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Beike Biotechnology Cellular Therapy Products Product Portfolio Table 67. Beike Biotechnology Recent Development Table 68. Fujifilm Cellular Dynamics Company Information Table 69. Fujifilm Cellular Dynamics Business Overview Table 70. Fujifilm Cellular Dynamics Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Fujifilm Cellular Dynamics Cellular Therapy Products Product Portfolio Table 72. Fujifilm Cellular Dynamics Recent Development Table 73. Gilead Sciences Company Information Table 74. Gilead Sciences Business Overview Table 75. Gilead Sciences Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Gilead Sciences Cellular Therapy Products Product Portfolio Table 77. Gilead Sciences Recent Development Table 78. Golden Meditech Company Information Table 79. Golden Meditech Business Overview Table 80. Golden Meditech Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Golden Meditech Cellular Therapy Products Product Portfolio Table 82. Golden Meditech Recent Development Table 83. Guanhao Biotech Company Information Table 84. Guanhao Biotech Business Overview Table 85. Guanhao Biotech Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Guanhao Biotech Cellular Therapy Products Product Portfolio Table 87. Guanhao Biotech Recent Development Table 88. JCR Pharmaceuticals Company Information Table 89. JCR Pharmaceuticals Business Overview Table 90. JCR Pharmaceuticals Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. JCR Pharmaceuticals Cellular Therapy Products Product Portfolio Table 92. JCR Pharmaceuticals Recent Development Table 93. Osiris Company Information Table 94. Osiris Business Overview Table 95. Osiris Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Osiris Cellular Therapy Products Product Portfolio Table 97. Osiris Recent Development Table 98. Vcanbio Company Information Table 99. Vcanbio Business Overview Table 100. Vcanbio Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Vcanbio Cellular Therapy Products Product Portfolio Table 102. Vcanbio Recent Development Table 103. Vericel Corporation Company Information Table 104. Vericel Corporation Business Overview Table 105. Vericel Corporation Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Vericel Corporation Cellular Therapy Products Product Portfolio Table 107. Vericel Corporation Recent Development Table 108. Novartis Company Information Table 109. Novartis Business Overview Table 110. Novartis Cellular Therapy Products Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Novartis Cellular Therapy Products Product Portfolio Table 112. Novartis Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Cellular Therapy Products Distributors List Table 116. Cellular Therapy Products Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Cellular Therapy Products Product Image Figure 2. Global Cellular Therapy Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cellular Therapy Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Cellular Therapy Products Sales (2021-2032) & (K Units) Figure 5. Global Cellular Therapy Products Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cellular Therapy Products Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Stem Cell Type Image Figure 9. Non-Stem Cell Type Image Figure 10. Global Cellular Therapy Products Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cellular Therapy Products Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cellular Therapy Products Sales Market Share by Type (2021-2032) Figure 13. Global Cellular Therapy Products Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cellular Therapy Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cellular Therapy Products Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Others Image Figure 19. Global Cellular Therapy Products Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Cellular Therapy Products Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cellular Therapy Products Sales Market Share by Application (2021-2032) Figure 22. Global Cellular Therapy Products Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cellular Therapy Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cellular Therapy Products Revenue Market Share by Application (2021-2032) Figure 25. North America Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Cellular Therapy Products Sales Market Share by Country (2021-2032) Figure 27. U.S. Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cellular Therapy Products Sales Market Share by Country (2021-2032) Figure 32. Germany Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cellular Therapy Products Sales Market Share by Country (2021-2032) Figure 39. China Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cellular Therapy Products Sales Market Share by Country (2021-2032) Figure 47. Brazil Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Cellular Therapy Products Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Cellular Therapy Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cellular Therapy Products Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cellular Therapy Products Revenue (2021-2032) & (US$ Million) Figure 58. North America Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cellular Therapy Products Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cellular Therapy Products Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cellular Therapy Products Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cellular Therapy Products Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cellular Therapy Products Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell Type
  • Non-Stem Cell Type
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Beike Biotechnology
  • Fujifilm Cellular Dynamics
  • Gilead Sciences
  • Golden Meditech
  • Guanhao Biotech
  • JCR Pharmaceuticals
  • Osiris
  • Vcanbio
  • Vericel Corporation
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cellular Therapy Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cellular Therapy Products Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cellular Therapy Products Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cellular Therapy Products Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cellular Therapy Products Market Dynamics
  1. 2.1 Cellular Therapy Products Industry Trends
  2. 2.2 Cellular Therapy Products Industry Drivers
  3. 2.3 Cellular Therapy Products Industry Opportunities and Challenges
  4. 2.4 Cellular Therapy Products Industry Restraints
3 Cellular Therapy Products Market by Manufacturers
  1. 3.1 Global Cellular Therapy Products Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cellular Therapy Products Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cellular Therapy Products Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cellular Therapy Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cellular Therapy Products Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cellular Therapy Products Manufacturers, Product Type & Application
  7. 3.7 Global Cellular Therapy Products Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cellular Therapy Products Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cellular Therapy Products Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cellular Therapy Products Tier 1, Tier 2, and Tier 3
4 Cellular Therapy Products Market by Type
  1. 4.1 Cellular Therapy Products Type Introduction
  2. 4.1.1 Stem Cell Type
  3. 4.1.2 Non-Stem Cell Type
  4. 4.2 Global Cellular Therapy Products Sales by Type
  5. 4.2.1 Global Cellular Therapy Products Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cellular Therapy Products Sales by Type (2021-2032)
  7. 4.2.3 Global Cellular Therapy Products Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cellular Therapy Products Revenue by Type
  9. 4.3.1 Global Cellular Therapy Products Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cellular Therapy Products Revenue by Type (2021-2032)
  11. 4.3.3 Global Cellular Therapy Products Revenue Market Share by Type (2021-2032)
5 Cellular Therapy Products Market by Application
  1. 5.1 Cellular Therapy Products Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Cellular Therapy Products Sales by Application
  6. 5.2.1 Global Cellular Therapy Products Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cellular Therapy Products Sales by Application (2021-2032)
  8. 5.2.3 Global Cellular Therapy Products Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cellular Therapy Products Revenue by Application
  10. 5.3.1 Global Cellular Therapy Products Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cellular Therapy Products Revenue by Application (2021-2032)
  12. 5.3.3 Global Cellular Therapy Products Revenue Market Share by Application (2021-2032)
6 Global Cellular Therapy Products Sales by Region
  1. 6.1 Global Cellular Therapy Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cellular Therapy Products Sales by Region (2021-2032)
  3. 6.2.1 Global Cellular Therapy Products Sales by Region (2021-2026)
  4. 6.2.2 Global Cellular Therapy Products Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cellular Therapy Products Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cellular Therapy Products Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cellular Therapy Products Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cellular Therapy Products Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cellular Therapy Products Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cellular Therapy Products Revenue by Region
  1. 7.1 Global Cellular Therapy Products Revenue by Region
  2. 7.1.1 Global Cellular Therapy Products Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cellular Therapy Products Revenue by Region (2021-2026)
  4. 7.1.3 Global Cellular Therapy Products Revenue by Region (2027-2032)
  5. 7.1.4 Global Cellular Therapy Products Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cellular Therapy Products Revenue (2021-2032)
  8. 7.2.2 North America Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cellular Therapy Products Revenue (2021-2032)
  11. 7.3.2 Europe Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cellular Therapy Products Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cellular Therapy Products Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cellular Therapy Products Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Beike Biotechnology
  2. 8.1.1 Beike Biotechnology Company Information
  3. 8.1.2 Beike Biotechnology Business Overview
  4. 8.1.3 Beike Biotechnology Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Beike Biotechnology Cellular Therapy Products Product Portfolio
  6. 8.1.5 Beike Biotechnology Recent Developments
  7. 8.2 Fujifilm Cellular Dynamics
  8. 8.2.1 Fujifilm Cellular Dynamics Company Information
  9. 8.2.2 Fujifilm Cellular Dynamics Business Overview
  10. 8.2.3 Fujifilm Cellular Dynamics Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fujifilm Cellular Dynamics Cellular Therapy Products Product Portfolio
  12. 8.2.5 Fujifilm Cellular Dynamics Recent Developments
  13. 8.3 Gilead Sciences
  14. 8.3.1 Gilead Sciences Company Information
  15. 8.3.2 Gilead Sciences Business Overview
  16. 8.3.3 Gilead Sciences Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gilead Sciences Cellular Therapy Products Product Portfolio
  18. 8.3.5 Gilead Sciences Recent Developments
  19. 8.4 Golden Meditech
  20. 8.4.1 Golden Meditech Company Information
  21. 8.4.2 Golden Meditech Business Overview
  22. 8.4.3 Golden Meditech Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Golden Meditech Cellular Therapy Products Product Portfolio
  24. 8.4.5 Golden Meditech Recent Developments
  25. 8.5 Guanhao Biotech
  26. 8.5.1 Guanhao Biotech Company Information
  27. 8.5.2 Guanhao Biotech Business Overview
  28. 8.5.3 Guanhao Biotech Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guanhao Biotech Cellular Therapy Products Product Portfolio
  30. 8.5.5 Guanhao Biotech Recent Developments
  31. 8.6 JCR Pharmaceuticals
  32. 8.6.1 JCR Pharmaceuticals Company Information
  33. 8.6.2 JCR Pharmaceuticals Business Overview
  34. 8.6.3 JCR Pharmaceuticals Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 JCR Pharmaceuticals Cellular Therapy Products Product Portfolio
  36. 8.6.5 JCR Pharmaceuticals Recent Developments
  37. 8.7 Osiris
  38. 8.7.1 Osiris Company Information
  39. 8.7.2 Osiris Business Overview
  40. 8.7.3 Osiris Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Osiris Cellular Therapy Products Product Portfolio
  42. 8.7.5 Osiris Recent Developments
  43. 8.8 Vcanbio
  44. 8.8.1 Vcanbio Company Information
  45. 8.8.2 Vcanbio Business Overview
  46. 8.8.3 Vcanbio Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vcanbio Cellular Therapy Products Product Portfolio
  48. 8.8.5 Vcanbio Recent Developments
  49. 8.9 Vericel Corporation
  50. 8.9.1 Vericel Corporation Company Information
  51. 8.9.2 Vericel Corporation Business Overview
  52. 8.9.3 Vericel Corporation Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vericel Corporation Cellular Therapy Products Product Portfolio
  54. 8.9.5 Vericel Corporation Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Cellular Therapy Products Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Cellular Therapy Products Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cellular Therapy Products Value Chain Analysis
  2. 9.1.1 Cellular Therapy Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cellular Therapy Products Production Mode & Process
  6. 9.2 Cellular Therapy Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cellular Therapy Products Distributors
  9. 9.2.3 Cellular Therapy Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst